These tumor-specific T-cells were generated using splenocytes of GREAT mice and were co-transferred into tumor-bearing mice that received infusion of different stem and progenitor cell populations (Sca1+HSCs, cKit+HSCs, CD133+HSCs, CD38+HSCs, or CCR2+HSCs). This evidence concerns the gene CD38 and neoplasm.